Share ownership Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 04:57:38 22/01/2026 pm IST			5-day change	1st Jan Change
43.86 ^EUR	+2.75%		+5.41%	+18.68%

01:08pm	Bayer AG - FDA grants orphan drug designation to cell therapy OPCT-001	RE
10:47am	DAVOS: Top Executive Fears Widening Economic Gap with the US	DP

Share class: Bayer AG

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	98,24,24,082	98,24,24,082 ( 100 %)	0	100 %

Major shareholders: Bayer AG

Name	Equities	%	Valuation
Silchester International Investors LLP 2.994 %	2,94,09,766	2.994 %	1 280 M €
Harris Associates LP 2.981 %	2,92,85,913	2.981 %	1 274 M €
Amundi Asset Management SASU (Investment Management) 2.971 %	2,91,88,372	2.971 %	1 270 M €
Dodge & Cox 2.874 %	2,82,33,293	2.874 %	1 229 M €
Cobas Asset Management SGIIC SA 0.2335 %	22,94,134	0.2335 %	100 M €
CapitalatWork SA 0.1723 %	16,92,317	0.1723 %	74 M €
Sjunde AP-fonden 0.1373 %	13,49,030	0.1373 %	59 M €
Research Affiliates LLC 0.095 %	9,33,637	0.095 %	41 M €
FIL Investments International (Germany) 0.0836 %	8,21,505	0.0836 %	36 M €
DIVAS Asset Management AG 0.0803 %	7,88,658	0.0803 %	34 M €
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Kahn Brothers Group, Inc. 0.1727 %	67,87,253	0.1727 %	74 M €
Dodge & Cox 0.0398 %	15,62,425	0.0398 %	17 M €
Goldman Sachs Asset Management International 0.007721 %	3,03,393	0.007721 %	3 M €
Great Lakes Advisors LLC 0.003615 %	1,42,040	0.003615 %	2 M €
RhumbLine Advisers LP 0.001775 %	69,761	0.001775 %	758 093 €
Yousif Capital Management LLC 0.001655 %	65,040	0.001655 %	706 790 €
GAMMA Investing LLC 0.000948 %	37,264	0.000948 %	404 948 €
Moloney Securities Asset Management LLC 0.00077 %	30,240	0.00077 %	328 618 €
Wintrust Private Trust Co. NA 0.000692 %	27,191	0.000692 %	295 485 €
Ayalon Mutual Funds Ltd. 0.000445 %	17,500	0.000445 %	190 173 €
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	14.3%
Other	0.69%
Unknown	85.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	6.94%
United Kingdom	3.26%
France	3.03%
Spain	0.39%
Germany	0.3%
Belgium	0.18%
Switzerland	0.16%
Sweden	0.14%
Luxembourg	0.12%
Italy	0.12%
Ireland	0.09%
South Africa	0.07%
Austria	0.06%
Denmark	0.04%
Finland	0.02%
Japan	0.02%
Australia	0.01%
Greece	0.01%
Canada	0.01%
China	0.01%
Hong Kong	0.01%
Norway	0.01%
Liechtenstein	0.01%

Based on 1000 largest holdings

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

88,502

Sector

Pharmaceuticals

Calendar

25/02 - Q4 2025 Earnings Release

More about the company